The Current Compounding Chapter: GLP-1s, Peptides, and Enforcement Trends
When:
Hosted By:
Food and Drug Law Institute (FDLI) Enforcement, Litigation, and Compliance Conference: For the Drug, Device, Food, and Tobacco Industries
People:
Location:
Washington DC & Virtual
Location
Share on:
The rapid growth of compounded GLP-1s and peptides has brought new attention to 503A and 503B compounding, telehealth prescribing practices, and API sourcing. This session explores recent actions involving telehealth marketing practices, individualized medical necessity and copy analyses, product quality and dosing concerns, and enforcement trends. Speakers will discuss practical compliance strategies for compounders, prescribers, platforms, distributors, and manufacturers.
Speakers:
Julie A. Dohm, Partner, Covington & Burling
Kalah Auchincloss, Co-Founder, President & Principal, Canal Row Advisors
Marc Wagner, Partner, Fox Rothschild
Moderator:
Marc Wagner, Partner, Fox Rothschild
Please note there is a cost to attend.
